Authors:
GALASKO D
CHANG L
MOTTER R
CLARK CM
KAYE J
KNOPMAN D
THOMAS R
KHOLODENKO D
SCHENK D
LIEBERBURG I
MILLER B
GREEN R
BASHERAD R
KERTILES L
BOSS MA
SEUBERT P
Citation: D. Galasko et al., HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE, Archives of neurology, 55(7), 1998, pp. 937-945
Authors:
CITRON M
WESTAWAY D
XIA WM
CARLSON G
DIEHL T
LEVESQUE G
JOHNSONWOOD K
LEE M
SEUBERT P
DAVIS A
KHOLODENKO D
MOTTER R
SHERRINGTON R
PERRY B
YAO H
STROME R
LIEBERBURG I
ROMMENS J
KIM S
SCHENK D
FRASER P
HYSLOP PS
SELKOE DJ
Citation: M. Citron et al., MUTANT PRESENILINS OF ALZHEIMERS-DISEASE INCREASE PRODUCTION OF 42-RESIDUE AMYLOID BETA-PROTEIN IN BOTH TRANSFECTED CELLS AND TRANSGENIC MICE, Nature medicine, 3(1), 1997, pp. 67-72
Authors:
SEUBERT PA
MOTTER RN
SCHENK DB
LIEBERBURG IM
KHOLODENKO D
GALASKO D
THOMAS R
CHANG L
MILLER B
CLARK C
KNOPMAN DS
KAYE J
GREEN RC
KERTILES L
BASHIRZADEH R
BOSS MA
Citation: Pa. Seubert et al., APOE GENOTYPE INFLUENCES THE CSF LEVEL OF A-BETA-42 IN ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63006-63006
Authors:
GALASKO D
SEUBERT P
MOTTER R
SCHENK D
KHOLODENKO D
LIEBERBURG I
CHANG L
MILLER B
CLARK C
KAYE J
CAMICIOLI R
KNOPMAN D
GREEN RC
THOMAS R
KERTILES L
BOSS M
Citation: D. Galasko et al., CSF LEVELS OF A-BETA-432 AND TAU AS AIDS TO DIAGNOSING ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63008-63008
Authors:
XIA WM
ZHANG JM
KHOLODENKO D
CITRON M
PODLISNY MB
TEPLOW DB
HAASS C
SEUBERT P
KOO EH
SELKOE DJ
Citation: Wm. Xia et al., ENHANCED PRODUCTION AND OLIGOMERIZATION OF THE 42-RESIDUE AMYLOID BETA-PROTEIN BY CHINESE-HAMSTER OVARY CELLS STABLY EXPRESSING MUTANT PRESENILINS, The Journal of biological chemistry, 272(12), 1997, pp. 7977-7982
Authors:
QIU WQ
YE Z
KHOLODENKO D
SEUBERT P
SELKOE DJ
Citation: Wq. Qiu et al., DEGRADATION OF AMYLOID BETA-PROTEIN BY A METALLOPROTEASE SECRETED BY MICROGLIA AND OTHER NEURAL AND NONNEURAL CELLS, The Journal of biological chemistry, 272(10), 1997, pp. 6641-6646
Authors:
MOTTER R
VIGOPELFREY C
KHOLODENKO D
BARBOUR R
JOHNSONWOOD K
GALASKO D
CHANG L
MILLER B
CLARK C
GREEN R
OLSON D
SOUTHWICK P
WOLFERT R
MUNROE B
LIEBERBURG I
SEUBERT P
SCHENK D
Citation: R. Motter et al., REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE, Annals of neurology, 38(4), 1995, pp. 643-648